diazooxonorleucine and Obesity

diazooxonorleucine has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gao, F; Jiang, T; Jin, L; Li, C; Liu, B; Qin, X; Zheng, Q1
Ambrosius, WT; Considine, RV; Cooksey, RC; Fawcett, RL; Huse, J; Inman, M; Jones, R; McClain, DA; Whitfield, RM; Williams, LB; Zhang, P1

Other Studies

2 other study(ies) available for diazooxonorleucine and Obesity

ArticleYear
Hyper-O-GlcNAcylation impairs insulin response against reperfusion-induced myocardial injury and arrhythmias in obesity.
    Biochemical and biophysical research communications, 2021, 06-18, Volume: 558

    Topics: Acetylglucosamine; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Cell Hypoxia; Cell Line; Diazooxonorleucine; Disease Models, Animal; Glycosylation; Humans; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardial Reperfusion Injury; Myocardium; Obesity; Protein Processing, Post-Translational; Rats

2021
Hexosamines regulate leptin production in human subcutaneous adipocytes.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:10

    Topics: Adipocytes; Body Mass Index; Cells, Cultured; Diazooxonorleucine; Glucosamine; Hexosamines; Humans; In Vitro Techniques; Leptin; Obesity; Stimulation, Chemical; Uridine Diphosphate N-Acetylglucosamine

2000